BioForce Nanosciences (OTCMKTS:BFNH) Shares Down 36.9% – Should You Sell?

BioForce Nanosciences Holdings Inc. (OTCMKTS:BFNHGet Free Report) traded down 36.9% on Wednesday . The stock traded as low as $0.55 and last traded at $0.55. 1,435 shares traded hands during trading, a decline of 58% from the average session volume of 3,424 shares. The stock had previously closed at $0.8720.

BioForce Nanosciences Price Performance

The firm has a fifty day simple moving average of $0.58 and a two-hundred day simple moving average of $0.58. The firm has a market capitalization of $29.25 million, a P/E ratio of -29.06 and a beta of -0.32.

BioForce Nanosciences Company Profile

(Get Free Report)

BioForce Nanosciences, Inc develops and markets precision instrumentation and proprietary technologies for the production and application of nanoscale materials. Its core platform employs nozzle-driven electrohydrodynamic processes to generate and deposit nanofibers, nanowires and nanoparticles with tight control over diameter, morphology and spatial arrangement. By tailoring electric field parameters and solution properties, the technology enables reproducible fabrication of structures at the nanometer scale.

The company’s product portfolio includes desktop electrospinning systems for nanofiber fabrication, electrospray modules for nanoparticle synthesis and integrated tools for bioprinting and surface patterning.

Featured Stories

Receive News & Ratings for BioForce Nanosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioForce Nanosciences and related companies with MarketBeat.com's FREE daily email newsletter.